YAP1 and cancer: Recently, in in vitro and in vivo, verteporfin (VP) and VGLL4-mimicking peptides have been utilized to inhibit YAP/TAZ activity, tissue growth, and cancer, however additional development of these medicines may be necessary for therapeutic usage.